Literature DB >> 28705808

Molecular Basis of Altered hERG1 Channel Gating Induced by Ginsenoside Rg3.

Alison Gardner1, Wei Wu1, Steven Thomson1, Eva-Maria Zangerl-Plessl1, Anna Stary-Weinzinger1, Michael C Sanguinetti2.   

Abstract

Outward current conducted by human ether-à-go-go-related gene type 1 (hERG1) channels is a major determinant of action potential repolarization in the human ventricle. Ginsenoside 20(S)-Rg3 [Rg3; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol], an alkaloid isolated from the root of Panax ginseng, slows the rate of hERG1 deactivation, induces channels to open at more negative potentials than normal, and increases current magnitude. The onset of Rg3 action is extremely fast, suggesting that it binds to an extracellular accessible site on the channel to alter its gating. Here we used a scanning mutagenesis approach to identify residues in the extracellular loops and transmembrane segments of hERG1 that might interact with Rg3. Single or multiple residues of hERG1 were mutated to Ala or Cys and the resulting mutant channels were heterologously expressed in Xenopus oocytes. The effects of Rg3 on the voltage dependence of activation and the deactivation rate of mutant channel currents were characterized using the two-microelectrode voltage clamp technique. Mutation to Ala of specific residues in the S1 (Tyr420), S2 (Leu452, Phe463), and S4 (Ile521, Lys525) segments partially inhibited the effects of Rg3 on hERG1. The double mutant Y420A/L452A nearly eliminated the effects of Rg3 on voltage-dependent channel gating but did not prevent the increase in current magnitude. These findings together with molecular modeling suggest that Rg3 alters the gating of hERG1 channels by interacting with and stabilizing the voltage sensor domain in an activated state.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28705808      PMCID: PMC5588553          DOI: 10.1124/mol.117.108886

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.054


  40 in total

1.  Electrophysiological recording from Xenopus oocytes.

Authors:  W Stühmer
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

2.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

Review 3.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

4.  Molecular determinants of dofetilide block of HERG K+ channels.

Authors:  E Ficker; W Jarolimek; J Kiehn; A Baumann; A M Brown
Journal:  Circ Res       Date:  1998-02-23       Impact factor: 17.367

5.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.

Authors:  G Jones; P Willett; R C Glen
Journal:  J Mol Biol       Date:  1995-01-06       Impact factor: 5.469

6.  Cryo-EM Structure of the Open Human Ether-à-go-go-Related K+ Channel hERG.

Authors:  Weiwei Wang; Roderick MacKinnon
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 7.  Molecular Basis of Cardiac Delayed Rectifier Potassium Channel Function and Pharmacology.

Authors:  Wei Wu; Michael C Sanguinetti
Journal:  Card Electrophysiol Clin       Date:  2016-03-18

8.  Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243).

Authors:  Xulin Xu; Maurizio Recanatini; Marinella Roberti; Gea-Ny Tseng
Journal:  Mol Pharmacol       Date:  2008-03-27       Impact factor: 4.436

9.  Interactions between charged residues in the transmembrane segments of the voltage-sensing domain in the hERG channel.

Authors:  M Zhang; J Liu; M Jiang; D-M Wu; K Sonawane; H R Guy; G-N Tseng
Journal:  J Membr Biol       Date:  2005-10       Impact factor: 1.843

10.  Structure driven design of novel human ether-a-go-go-related-gene channel (hERG1) activators.

Authors:  Jiqing Guo; Serdar Durdagi; Mohamed Changalov; Laura L Perissinotti; Jason M Hargreaves; Thomas G Back; Sergei Y Noskov; Henry J Duff
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more
  2 in total

1.  Oxidized Glutathione Increases Delta-Subunit Expressing Epithelial Sodium Channel Activity in Xenopus laevis Oocytes.

Authors:  Garett J Grant; Camila Coca; Xing-Ming Zhao; My N Helms
Journal:  Emed Res       Date:  2020-05-25

Review 2.  Pharmacological activation of the hERG K+ channel for the management of the long QT syndrome: A review.

Authors:  Aziza El Harchi; Oriane Brincourt
Journal:  J Arrhythm       Date:  2022-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.